The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity

Shen, Y., Singh, J., Sah, B., Chen, Z., Ha, W., Henzler, C., Su, T., Xie, L., Deng, Y., Li, G., Guo, H., Hibshoosh, H., & Liu, L. (2022). The Histone Demethylase HR Suppresses Breast Cancer Development through Enhanced CELF2 Tumor Suppressor Activity. Cancers, 14(19), 4648. https://doi.org/10.3390/cancers14194648
Authors:
Yao Shen
Jasvinder Singh
Bindeshwar Sah
Zhongming Chen
Wootae Ha
Christine Henzler
Tao Su
Lillian Xie
Yibin Deng
Gen Li
Hua Guo
Hanina Hibshoosh
Liang Liu
Affiliated Authors:
Yao Shen
Tao Su
Hua Guo
Hanina Hibshoosh
Author Keywords:
celf2
breast cancer
epigenetic therapy
hairless
histone methylation
Publication Type:
Article
Unique ID:
10.3390/cancers14194648
Journal:
Publication Date:
Data Source:
Scopus

Record Created: